STXS

시간 외 거래: 1.86 0.01 +0.54%

Stereotaxis Inc (STXS)

개요 뉴스 가격 이력 옵션 체인 토론 예측 주식 분할

Relative Volume:

Stereotaxis Inc Stock (STXS) Company Profile

Stereotaxis Inc

Healthcare (1116)

314-678-6100

4320 Forest Park Avenue, Suite 100, St. Louis, MO

@stereotaxis

최신 SEC 제출 서류

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
STXS Stereotaxis Inc	1.85	178.94M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	464.45	163.73B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	156.34	44.73B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.51	36.73B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	44.00	36.12B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	222.85	32.70B	5.40B	1.49B	1.78B	10.12

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-12-16	개시	Citizens JMP	Mkt Outperform
2024-01-10	개시	ROTH MKM	Buy
2022-07-12	개시	Aegis Capital	Buy
2022-06-23	개시	B. Riley Securities	Buy
2022-01-05	개시	Craig Hallum	Buy
2022-01-05	개시	Loop Capital	Buy
2021-05-26	개시	Piper Sandler	Overweight
2020-09-08	개시	Northland Capital	Outperform
2020-04-09	개시	Cowen	Outperform
2020-04-07	개시	Lake Street	Buy

Stereotaxis Inc 주식(STXS)의 최신 뉴스

Stereotaxis Inc (STXS) 재무 분석

Stereotaxis Inc (STXS)

Stereotaxis Inc Stock (STXS) Company Profile

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Stereotaxis Inc 주식(STXS)의 최신 뉴스

Citizens upgrades Stereotaxis stock outlook on catheter ramp By Investing.com - Investing.com Canada

STXS PE Ratio & Valuation, Is STXS Overvalued - intellectia.ai

Stereotaxis, Inc. expands remote robotic testing with TeleRobotic Test Drive launch - Traders Union

Stereotaxis Inc. (STXS) reports Q4 loss, lags revenue estimates - msn.com

Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.2%Here's What Happened - MarketBeat

Aug Opening: Should I set a stop loss on Stereotaxis Inc2026 Sector Moves & Weekly Setup with ROI Potential - baoquankhu1.vn

Risk Check: Is Stereotaxis Inc being accumulated by smart money2026 Bull vs Bear & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Aug Fed Impact: What are the risks of holding Stereotaxis Inc2026 Highlights & Reliable Volume Spike Alerts - baoquankhu1.vn

Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris - Traders Union

[EFFECT] Stereotaxis, Inc. SEC Filing - Stock Titan

Stereotaxis (STXS) Announces First Robotic MAGiC Sweep Catheter Procedure at Deborah Heart and Lung Center - MSN

Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview - Traders Union

Analyst Calls: Can Stereotaxis Inc keep up with sector leaders2026 Major Catalysts & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Stereotaxis (NYSE American: STXS) registers $79.6M unsold securities, adds $42.1M ATM balance - Stock Titan

Stereotaxis (STXS) to Participate in BTIG Hosted Virtual Meeting - GuruFocus

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS) - Seeking Alpha

Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN

Stereotaxis Inc. 2025 Annual Report: Robotic Magnetic Navigation Systems, Strategic Partnerships, and Market Overview - Minichart

Stereotaxis (NYSE: STXS) details 2025 backlog, APT deal and catheter shift - Stock Titan

Stereotaxis 10-K: $32.4M Revenue, $(0.25) EPS - TradingView

32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts - Traders Union

Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus

Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada

Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus

Stereotaxis Q4 Earnings Call Highlights - MarketBeat

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget

Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada

Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus

STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus

Stereotaxis reports 20% revenue growth - The Business Journals

Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView

Stereotaxis (NYSE: STXS) posts 20% 2025 revenue growth and eyes $40M+ in 2026 - Stock Titan

Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga

Stereotaxis Reports 2025 Full Year Financial Results - ChartMill

Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union

Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn

AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com

Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus

Preview: Stereotaxis's Earnings - Benzinga

Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World

Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn

STXS SEC FilingsStereotaxis Ord 10-K, 10-Q, 8-K Forms - Stock Titan

Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union

Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat

STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com

Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN

Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union

Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat

STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru

Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat

Stereotaxis Inc (STXS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

STXS과 유사한 종목